| Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores C Bianco, O Jamialahmadi, S Pelusi, G Baselli, P Dongiovanni, I Zanoni, ... Journal of hepatology 74 (4), 775-782, 2021 | 229 | 2021 |
| The TM6SF2 E167K genetic variant induces lipid biosynthesis and reduces apolipoprotein B secretion in human hepatic 3D spheroids S Prill, A Caddeo, G Baselli, O Jamialahmadi, P Dongiovanni, R Rametta, ... Scientific reports 9 (1), 11585, 2019 | 100 | 2019 |
| Exome-wide association study on alanine aminotransferase identifies sequence variants in the GPAM and APOE associated with fatty liver disease O Jamialahmadi, RM Mancina, E Ciociola, F Tavaglione, PK Luukkonen, ... Gastroenterology 160 (5), 1634-1646. e7, 2021 | 96 | 2021 |
| Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease O Govaere, SK Petersen, N Martinez-Lopez, J Wouters, M Van Haele, ... Journal of hepatology 76 (5), 1001-1012, 2022 | 71 | 2022 |
| A polygenic risk score to refine risk stratification and prediction for severe liver disease by clinical fibrosis scores A De Vincentis, F Tavaglione, O Jamialahmadi, A Picardi, RA Incalzi, ... Clinical Gastroenterology and Hepatology 20 (3), 658-673, 2022 | 67 | 2022 |
| MBOAT7 is anchored to endomembranes by six transmembrane domains A Caddeo, O Jamialahmadi, G Solinas, A Pujia, RM Mancina, P Pingitore, ... Journal of Structural Biology 206 (3), 349-360, 2019 | 57 | 2019 |
| Rare ATG7 genetic variants predispose patients to severe fatty liver disease GA Baselli, O Jamialahmadi, S Pelusi, E Ciociola, F Malvestiti, M Saracino, ... Journal of Hepatology 77 (3), 596-606, 2022 | 45 | 2022 |
| Development and validation of a score for fibrotic nonalcoholic steatohepatitis F Tavaglione, O Jamialahmadi, A De Vincentis, S Qadri, ME Mowlaei, ... Clinical Gastroenterology and Hepatology 21 (6), 1523-1532. e1, 2023 | 44 | 2023 |
| Experiments and a three‐phase computational fluid dynamics (CFD) simulation coupled with population balance equations of a stirred tank bioreactor for high cell density cultivation H Azargoshasb, SM Mousavi, O Jamialahmadi, SA Shojaosadati, ... The Canadian Journal of Chemical Engineering 94 (1), 20-32, 2016 | 33 | 2016 |
| Experimental study and CFD simulation of phenol removal by immobilization of soybean seed coat in a packed-bed bioreactor F Rezvani, H Azargoshasb, O Jamialahmadi, S Hashemi-Najafabadi, ... Biochemical Engineering Journal 101, 32-43, 2015 | 33 | 2015 |
| Recent advances in hepatocellular carcinoma treatment ND Parikh, A Pillai Clinical Gastroenterology and Hepatology 19 (10), 2020-2024, 2021 | 32 | 2021 |
| Lack of genetic evidence that fatty liver disease predisposes to COVID-19 L Valenti, O Jamialahmadi, S Romeo Journal of Hepatology 73 (3), 709, 2020 | 30 | 2020 |
| A benchmark-driven approach to reconstruct metabolic networks for studying cancer metabolism O Jamialahmadi, S Hashemi-Najafabadi, E Motamedian, S Romeo, ... PLoS computational biology 15 (4), e1006936, 2019 | 25 | 2019 |
| CFD simulation of fluid flow in a novel prototype radial mixed plug-flow reactor M Rasouli, SM Mousavi, H Azargoshasb, O Jamialahmadi, Y Ajabshirchi Journal of Industrial and Engineering Chemistry 64, 124-133, 2018 | 24 | 2018 |
| PSD3 downregulation confers protection against fatty liver disease RM Mancina, K Sasidharan, A Lindblom, Y Wei, E Ciociola, ... Nature metabolism 4 (1), 60-75, 2022 | 23 | 2022 |
| Disease-specific eQTL screening reveals an anti-fibrotic effect of AGXT2 in non-alcoholic fatty liver disease T Yoo, SK Joo, HJ Kim, HY Kim, H Sim, J Lee, HH Kim, S Jung, Y Lee, ... Journal of Hepatology 75 (3), 514-523, 2021 | 21 | 2021 |
| Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery F Tavaglione, A De Vincentis, V Bruni, IF Gallo, S Carotti, D Tuccinardi, ... Liver International 42 (2), 374-383, 2022 | 18 | 2022 |
| Inborn and acquired risk factors for severe liver disease in Europeans with type 2 diabetes from the UK Biobank F Tavaglione, A De Vincentis, O Jamialahmadi, R Pujia, R Spagnuolo, ... JHEP Reports 3 (3), 100262, 2021 | 16 | 2021 |
| Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women A Cherubini, M Ostadreza, O Jamialahmadi, S Pelusi, E Rrapaj, E Casirati, ... Nature Medicine 29 (10), 2643-2655, 2023 | 14 | 2023 |
| Remediation of a diesel-contaminated soil using a Fenton-like advanced oxidation process: optimization by response surface methodology N Jamialahmadi, S Gitipour, O Jamialahmadi, M Baghdadi Soil and Sediment Contamination: An International Journal 24 (6), 609-623, 2015 | 14 | 2015 |
